WePlay App 4th Anniversary Carnival: A Grand Social Gathering Where Play Brings Friends Together!
TAIPEI, April 2, 2025 /PRNewswire/ -- As a renowned app blending casual tabletop games and voice-based interactions, WePlay App has consistently innovated to reward its players. This year, it launched exciting new titles, including the...
CNOOC Limited Subsidiary Completed the Transaction with INEOS Energy
HONG KONG, April 2, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that its wholly owned subsidiary, CNOOC International Limited, has completed closing of the Stock...
Sino Inno Lab and the Spark Promote I&T Integration in Daily Life
Engaging Over 2,000 Individuals in Its First Year in the Northern Metropolis HONG KONG, April 2, 2025 /PRNewswire/ -- Sino Group ('The Group') is dedicated to nurturing and attracting talent while supporting the development of the innovation and...
Veda KM (CSRone) Recognized as Best Sustainability Advisory Firm by Acquisition International in UK, Creating Corporate Value with Collaborative Counseling!
TAIPEI, April 2, 2025 /PRNewswire/ -- Veda KM (CSRone), Veda International Group's Sustainability Consultation Team, becomes Taiwan's only firm to be awarded the Best Sustainability Advisory Firm by Acquisition International, demonstrating the...
Data4Life releases Data2Evidence as open source: a new chapter for global health research
POTSDAM, Germany, April 2, 2025 /PRNewswire/ -- Data4Life, the nonprofit digital health organization, today announced the open-source release of its research platform Data2Evidence (D2E). With this move, Data4Life is equipping researchers and...
One Bangkok Drenches the City in Songkran Joy: "One Bangkok, One Lagoon Splashing Songkran Rhythms" - The Ultimate Songkran Celebration for Everyone
BANGKOK, April 2, 2025 /PRNewswire/ -- One Bangkok invites everyone to immerse themselves in the spirit of Songkran 2025 with "One Bangkok, One Lagoon Splashing Songkran Rhythms." Transforming the heart of Bangkok into a vibrant oasis, this event...
Senhwa Biosciences Announces Positive Clinical Data from Phase 1/Expansion Trial of Silmitasertib (CX-4945) in the Treatment of Basal Cell Carcinoma
Basal Cell Carcinoma CSR Highlights CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Response: Three patients achieved partial response (PR), while ten patients had stable disease (SD)....
Over 2/3 of Companies Surveyed Believe that Reciprocal Tariffs Present Greater Concerns for Business
Survey by The American Chamber of Commerce in Singapore (AmChamSG) Reveals a Complex Picture of Concern and Caution Among Business SINGAPORE, April 2, 2025 /PRNewswire/ -- The American Chamber of Commerce in Singapore (AmChamSG), in collaboration...